Page 247«..1020..246247248249..260270..»

Principal Component Analyses (PCA)-based findings in population genetic studies are highly biased and must be reevaluated | Scientific Reports -…

Posted: August 30, 2022 at 3:01 am

The near-perfect case of dimensionality reduction

Applying principal component analysis (PCA) to a dataset of four populations sampled evenly: the three primary colors (Red, Green, and Blue) and Black illustrate a near-ideal dimension reduction example. PCA condensed the dataset of these four samples from a 3D Euclidean space (Fig.1B) into three principal components (PCs), the first two of which explained 88% of the variation and can be visualized in a 2D scatterplot(Fig.1C). Here, and in all other color-based analyses, the colors represent the true 3D structure, whereas their positions on the 2D plots are the outcome of PCA. Although PCA correctly positioned the primary colors at even distances from each other and Black, it distorted the distances between the primary colors and Black (from 1 in 3D space to 0.82 in 2D space). Thereby, even in this limited and near-perfect demonstration of data reduction, the observed distances do not reflect the actual distances between the samples (which are impossible to recreate in a 2D dataset). In other words, distances between samples in a reduced dimensionality plot do not and cannot be expected to represent actual genetic distances. Evenly increasing all the sample sizes yields identical results irrespective of the sample size (Fig.1D,E).

When analyzing human populations, which harbor most of the genomic variation between continental populations (12%) with only 1% of the genetic variation distributed within continental populations39, PCA tends to position Africans, Europeans, and East Asians at the corners of an imaginary triangle, which closely resembles our color-population model and illustration. Analyzing continental populations, we obtained similar results for two even-sized sample datasets (Fig.2A,C) and their quadrupled counterparts (Fig.2B,D). As before, the distances between the populations remain similar (Fig.2AD), demonstrating that for same-sized populations, sample size does not contribute to the distortion of the results if the increase in size is proportional.

Testing the effect of even-sample sizes using two population sets. The top plots show nine populations with n=50 (A) and n=188 (B). The bottom plots show a different set of nine populations with n=50 (C) and n=192 (D). In both cases, increasing the sample size did not alter the PCs (the y-axis flip between (C) and (D) is a known phenomenon).

The extent to which different-sized populations produce results with conflicting interpretations is illustrated through a typical study case in Box 1.

Note that unlike in Figs.1C and 3A, where Black is in the middle, in other figures, the overrepresentation of certain alleles (e.g., Fig. 4B) shifts Black away from (0,0). Intuitively, this can be thought of as the most common allele (Green in Fig. 4B) repelling Black, which has three null or alternative alleles.

PCA is commonly reported as yielding a stable differentiation of continental populations (e.g., Africans vs. non-Africans, Europeans vs. Asians, and Asians vs. Native Americans or Oceanians, on the primary PCs40,41,42,43). This prompted prehistorical inferences of migrations and admixture, viewing the PCA results that position Africans, East Asians, and Europeans in three corners of an imaginary triangle as representing the post Out Of Africa event followed by multiple migrations, differentiation, and admixture events. Inferences for Amerindians or Aboriginals typically follow this reconstruction. For instance, Silva-Zolezzi et al.42 argued that the Zapotecosdid not experience a recent admixture due to their location on the AmerindianPCA cluster at the Asian end of the European-Asian cline.

Here we show that the appearance of continental populations at the corners of a triangle is an artifact of the sampling scheme since variable sample sizes can easily create alternative results as well as alternative clines. We first replicated the triangular depiction of continental populations (Fig. 3A,B) before altering it (Fig. 3CF). Now, East Asians appear as a three-way admixed group of Africans, Europeans, and Melanesians (Fig. 3C), whereas Europeans appear on an African-East Asian cline (Fig. 3D). Europeans can also be made to appear in the middle of the plot as an admixed group of Africans-Asians-Oceanians origins (Fig. 3E), and Oceanians can cluster with (Fig. 3F) or without East Asians (Fig. 3E). The latter depiction maximizes the proportion of explained variance, which common wisdom would consider the correct explanation. According to some of these results, only Europeans and Oceanians (Fig. 3C) or East Asians and Oceanians (Fig. 3D) experienced the Out of Africa event. By contrast, East Asians (Fig. 3C) and Europeans (Fig. 3D) may have remained in Africa. Contrary to Silva-Zolezzi et al.s42 claim, the same MexicanAmerican cohort can appear closer to Europeans (Fig. 3A) or as a European-Asian admixed group (Fig. 3B). It is easy to see that none of those scenarios stand out as more or less correct than the other ones.

PCA of uneven-sized African (Af), European (Eu), Asian (As), and Mexican-Americans (Ma) or Oceanian (Oc) populations. Fixing the sample size of Mexican-Americans and altering the sample sizes of other populations: (A) nAf=198; nEu=20; nAs=483; nMa=64 and (B) nAf=20; nEu=343; nMa=20; nAm=64 changes the results. An even more dramatic change can be seen when repeating this analysis on Oceanians: (C) nAf=5; nEu=25; nAs=10; nOce=20 and (D) nAfr=5; nEu=10; nAs=15; nOc=20 and when altering their sample sizes: (E) nAf=98; nEu=25; nAs=150; nOc=24 and (F) nAf=98; nEu=83; nAs=30; nOc=15.

Reich et al.44 presented further PCA-based evidence to the out of Africa scenario. Applying PCA to Africans and non-Africans, they reported that non-Africans cluster together at the center of African populations when PC1 was plotted against PC4 and that this rough cluster[ing] of non-Africans is about what would be expected if all non-African populations were founded by a single dispersal out of Africa. However, observing PC1 and PC4 for Supplementary Fig. S3, we found no rough cluster of non-Africans at the center of Africans, contrary to Reich et al.s44 claim. Remarkably, we found a rough cluster of Africans at the center of non-Africans (Supplementary Fig. S3C), suggesting that Africans were founded by a single dispersal into Africa by non-Africans. We could also infer, based on PCA, either that Europeans never left Africa (Supplementary Fig. S3D), that Europeansleft Africa through Oceania (Supplementary Fig. S3B), that Asians and Oceanians never left Europe (or the other way around) (Supplementary Fig. S3F), or,since all are valid PCA results,all of the above. Unlike Reich et al.44, we do not believe that their example highlights how PCA methods can provide evidence of important migration events. Instead, our examples (Fig. 3, Supplementary Fig. S3) show how PCA can be used to generate conflicting and absurd scenarios, all mathematically correct but, obviously, biologically incorrect and cherry-pick the most favorable solution. This is an example of how vital a priori knowledge is to PCA. It is thereby misleading to present one or a handful of PC plots without acknowledging the existence of many other solutions, let alone while not disclosing the proportion of explained variance.

Three research groups sought to study the origin of Black. A previous study that employed even sample-sized color populations alluded that Black is a mixture of all colors (Fig.1BD). A follow-up study with a larger sample size (nRed=nGreen=nBlue=10) and enriched in Black samples (nBlack=200) (Fig. 4A) reached the same conclusion. However, the Black-is-Blue group suspected that the Blue population was mixed. After QC procedures, the Blue sample size was reduced, which decreased the distance between Black and Blue and supported their speculation that Black has a Blue origin (Fig. 4B). The Black-is-Red group hypothesized that the underrepresentation of Green, compared to its actual population size, masks the Red origin of Black. They comprehensively sampled the Green population and showed that Black is very close to Red (Fig. 4C). Another Black-is-Red group contributed to the debate by genotyping more Red samples. To reduce the bias from other color populations, they kept the Blue and Green sample sizes even. Their results replicated the previous finding that Black is closer to Red and thereby shares a common origin with it (Fig. 4D). A new Black-is-Green group challenged those results, arguing that the small sample size and omission of Green samples biased the results. They increased the sample sizes of the populations of the previous study and demonstrated that Black is closer to Green (Fig. 4E). The Black-is-Blue group challenged these findings on the grounds of the relatively small sample sizes that may have skewed the results and dramatically increased all the sample sizes. However, believing that they are of Purple descent, Blue refused to participate in further studies. Their relatively small cohort was explained by their isolation and small effective population size. The results of the new sampling scheme confirmed that Black is closer to Blue (Fig. 4F), and the group was praised for the large sample sizes that, no doubt, captured the actual variation in nature better than the former studies.

PCA of uneven-sized samples of four color populations. (A) nRed=nGreen=nBlue=10; nBlack=200, (B) nRed=nGreen=10; nBlue=5; nBlack=200, (C) nRed=10; nGreen=200; nBlue=50; nBlack=200 (D) nRed=25; nGreen=nBlue=50; nBlack=200, (E) nRed=300; nGreen=200; nBlue=nBlack=300, and (F) nRed=1000; nGreen=2000; nBlue=300; nBlack=2000. Scatter plots show the top two PCs. The numbers on the grey bars reflect the Euclidean distances between the color populations over all PCs. Colors include Red [1,0,0], Green [0,1,0], Blue [0,0,1], and Black [0,0,0].

The question of who the ancestors of admixed populations are and the extent of their contribution to other groups is at the heart of population genetics. It may not be surprising that authors hold conflicting views on interpreting these admixtures from PCA. Here, we explore how an admixed group appears in PCA, whether its ancestral groups are identifiable, and how its presence affects the findings for unmixed groups through a typical study case (Box 2).

To understand the impact of parameter choices on the interpretation of PCA, we revisited the first large-scale study of Indian population history carried out by Reich et al.45. The authors applied PCA to a cohort of Indians, Europeans, Asians, and Africans using various sample sizes that ranged from 2 (Srivastava) (out of 132 Indians) to 203 (Yoruban) samples. After applying PCA to Indians and the three continental populations to exclude outliers that supposedly had more African or Asian ancestries than other samples, PCA was applied again in various settings.

At this point, the authors engaged in circular logic as, on the one hand, they removed samples that appeared via PCA to have experienced gene flow from Africa (their Note 2, iii) and, on the other hand, employed a priori claim (unsupported by historical documents) that African history has little to do with Indian history (which must stand in sharp contrast to the rich history of gene flow from Utah (US) residentsto Indians, which was equally unsupported). Reich et al. provided no justification for the exact protocol used or any discussion about the impact of using different parameter values on resulting clusters.They then generated a plethora of conflicting PCA figures, never disclosing the proportion of explained variance along with the first four PCs examined. They then inferred based on PCA that Gujarati Americans exhibit no unusual relatedness to West Africans (YRI) or East Asians (CHB or JPT) (Supplementary Fig. S4)45. Their concluding analysis of Indians, Asians, and Europeans (Fig. 4)45 showed Indians at the apex of a triangle with Europeans and Asians at the opposite corners. This plot was interpreted as evidence of an ancestry that is unique to India and an Indian cline. Indian groups were explained to have inherited different proportions of ancestry from Ancestral North Indians (ANI), related to western Eurasians, and Ancestral South Indians (ASI), who split from Onge. The authors then followed up with additional analyses using Africans as an outgroup, supposedly confirming the results of their selected PCA plot. Indians have since been described using the terms ANI and ASI.

In evaluating the claims of Reich et al.45 that rest on PCA, we first replicated the finding of the alleged Indian cline (Fig. 5A). We next garnered support for an alternative cline using Indians, Africans, and Europeans (Fig. 5B). We then demonstrated that PCA results support Indians to be European (Fig. 5C), East Asians (Fig. 5D), and Africans (Fig. 5E), as well as a genuinely European-Asian, admixed population (Fig. 5F). Whereas the first two PCs of Reich et al.s primary figure explain less than 8% of the variation (according to our Fig. 5A, Reich et al.s Fig. 4 does not report this information), four out of five of our alternative depictions explain 814% of the variation. Our results also expose the arbitrariness of the scheme used by Reich et al. and show how radically different clustering can be obtained merely by manipulating the non-Indian populations used in the analyses. Our results also question the authors choice in using an analysis that explained such a small proportion of the variation (let alone not reporting it), yielded no support for a unique ancestry to India, and cast doubt on the reliability and usefulness of the ANI-ASI model to describe Indians provided their exclusive reliability on a priori knowledge in interpreting the PCA patters. Although supported by downstream analyses, the plurality of PCA results could not be used to support the authors findings because using PCA, it is impossible to answer a priori whether Africa is in India or the other way around (Fig. 5E). We speculate tat the motivation for Reich et al.'s strategy was to declare Africans an outgroup, an essential component of D-statistics.Clearly, PCA-based a posteriori inferences can lead to errors of Colombian magnitude.

Studying the origin of Indians using PCA. (A) Replicating Reich et al.s 45 results using nEu=99; nAs=146; nInd=321. Generating alternative PCA scenarios using: (B) nAf=178; nEu=99; nInd=321, (C) nAf=400; nEu=40; nAs=100; nInd=321, (D) nAf=477; nEu=253; nAs=23; nInd=321, (E) nAf=25; nEu=220; nAs=490; nInd=320, and (F) nAf=30; nEu=200; nAs=50; nInd=320.

To evaluate the extent of deviation of PCA results from genetic distances, we adopted a simple genetic distance scheme where we measured the Euclidean distance between allelic counts (0,1,2) in the same data used for PCA calculations. We are aware of the diversity of existing genetic distance measures. However, to the best of our knowledge, no study has ever shown that PCA outcomes numerically correlate with any genetic distance measure, except in very simple scenarios and tools like ADMIXTURE-like tools, which, like PCA, exhibit high design flexibility. Plotting the genetic distances against those obtained from the top two PCs shows the deviation between these two measures for each dataset. We found that all the PC projections (Fig. 6) distorted the genetic distances in unexpected ways that differ between the datasets. PCA correctly represented the genetic distances for a minority of the populations, and just like the most poorly represented populationsnone were distinguishable from other populations. Moreover, populations that clustered under PCA exhibited mixed results, questioning the accuracy of PCA clusters. Although it remains unclear which sampling scheme to adopt, neither scheme is genetically accurate. These results further question the genetic validity of the ANI-ASI model.

Comparing the genetic distances with PCA-based distances for the corresponding datasets of Fig. 5. Genetic and PCA (PC1+PC2) distances between populations pairs (symbol pairs) and 2000 random individual pairs (grey dots) were calculated using Euclidean distances and normalized to range from 0 to 1. Population and individual pairs whose PC distances reflect their genetic distances are shown along the x=y dotted line. Note that the position of heterogeneous populations on the plot may deviate from that of their samples and that some populations are very small.

We are aware that PCA disciplesmay reject our reductio ad absurdum argument and attempt to read into these results, as ridiculous as they may be, a valid description of Indian ancestry. For those readers, demonstrating the ability of the experimenter to generate near-endless contradictory historical scenarios using PCA may be more convincing or at least exhausting. For brevity, we present six more such scenarios that show PCA support for Indians as a heterogeneous group with European admixture and Mexican-Americans as an Indian-European mixed population (Supplementary Fig. S4A), MexicanAmerican as an admixed African-European group with Indians as a heterogeneous group with European admixture (Supplementary Fig. S4B), Indians and Mexican-Americans as European-Japanese admixed groups with common origins and high genetic relatedness (Supplementary Fig. S4C), Indians and Mexican-Americans as European-Japanese admixed groups with no common origins and genetic relatedness (Supplementary Fig. S4D), Europans as Indian and Mexican-Americans admixed group with Japanese fully cluster with the latter (Supplementary Fig. S4E), and Japanese and Europeans cluster as an admixed Indian and Mexican-Americans groups (Supplementary Fig. S4F). Readers are encouraged to use our code to produce novel alternative histories.We suspect that almost any topology could be obtained by finding the right set of input parameters.In this sense, any PCA output can reasonably be considered meaningless.

Contrary to Reich et al.'s claims,a more common interpretation of PCA is that the populations at the corners of the triangle are ancestral or are related to the mixed groups within the triangle, which are the outcome of admixture events, typically referred to as gradient or clines45. However, some authors held different opinions. Studying the African component of Ethiopian genomes, Pagani et al.46 produced a PC plot showing Europeans (CEU), Yoruba (western African), and Ethiopians (Eastern Africans) at the corners of a triangle (Supplementary Fig. S4)46. Rather than suggesting that the populations within the triangle (e.g., Egyptians, Spaniards, Saudi) are mixtures of these supposedly ancestral populations, the authors argued that Ethiopians have western and eastern Africanorigins, unlike the central populations with different patterns of admixture. Obviously, neither interpretation is correct. Reich et al.s interpretation does not explain why CEUs are not an Indian-African admix nor why Africans are not a European-Indian admix and is analogous to arguing that Red has Green and Blue origins (Fig.1). Pagani et al.s interpretation is a tautology, ignores the contribution of non-Africans, and is analogous to arguing that Red has Red and Green origins. We carried out forward simulations of populations with various numbers of ancestral populations and found that admixture cannot be inferred from the positions of samples in a PCA plot (Supplementary Text 1).

In a separate effort to study the origins of AJs, Need et al.47 applied PCA to 55 Ashkenazic Jews (AJs) and 507 non-Jewish Caucasians. Their PCA plot showed that AJs (marked as Jews) formed a distinct cluster from Europeans (marked as non-Jews). Based on these results, the authors suggested that PCA can be used to detect linkage to Jewishness. A follow-up PCA where Middle Eastern (Bedouin, Palestinians, and Druze) and Caucasus (Adygei) populations were included showed that AJs formed a distinct cluster that nested between the Adygei (and the European cluster) and Druze (and the Middle Eastern cluster). The authors then concluded that AJs might have mixed Middle Eastern and European ancestries. The proximity to the Adygei cluster was noted as interesting but dismissed based on the small sample size of the Adygei (n=17). The authors concluded that AJ genomes carry an unambiguous signature of their Jewish heritage, and this seems more likely to be due to their specific Middle Eastern ancestry than to inbreeding. A similar strategy was employed by Bray et al.48 to claim that PCA confirmed that the AJ individuals cluster distinctly from Europeans, aligning closest to Southern European populations along with the first principal component, suggesting a more southern origin, and aligning with Central Europeans along the second, consistent with migration to this region. Other authors49,50 made similar claims.

It is easy to show why PCA cannot be used to reach such conclusions. We first replicated Need et al.s47 primary results (Fig. 7A), showing that AJs cluster separately from Europeans. However, such an outcome is typical when comparing Europeans and non-European populations like Turks (Fig. 7B). It is not unique to AJs, nor does it prove that they are genetically detectable. A slightly modified design shows that most AJs overlap with Turks in support of the Turkic (or Near Eastern) origin of AJs (Fig. 7C). We can easily refute our conclusion by including continental populations and showing that most AJs cluster with Iberians rather than Turks (Fig. 7D). This last design explains more of the variance than all the previous analyses together, although, as should be evident by now, it is not indicative of accuracy. This analysis questions PCA's use as a discriminatory genetic utility and to infer genetic ancestry.

Studying the origin of 55 AJs using PCA. (A) Replicating Need et al.s results using nEu=507; Generating alternative PCA scenarios using: (B) nEu=223; nTurks=56; (C) nEu=400; nTurks+Caucasus=56, and (D) nAf=100, nAs=100 (Africans and Asians are not shown), nEu=100; and nTurks=50.Need et al.'s faulty terminology was adopted in A and B.

There are several more oddities with the report of Need et al.47. First, they did not report the variance explained by their sampling scheme (it is, likely, ~1%, as in Fig. 7A). Second, they misrepresented the actual populations analyzed. AJs are not the only Jews, and Europeans are not the only non-Jews (Figs.1, 7A)47. Finally, their dual interpretations of AJs as a mixed population of Middle Eastern origin are based solely on a priori belief: first, because most of the populations in their PCA are nested between and within other populations, yet the authors did not suggest that they are all admixed and second because AJs nested between Adygii and Druze51,52, both formed in the Near Eastern. The conclusions of Need et al.47 were thereby obtained based on particular PCA schemes and what may be preconceived ideas of AJs origins that are no more real than the Iberian origin of AJs (Fig. 7D). This is yet another demonstration (discussed in Elhaik36) of how PCA can be misused to promote ethnocentric claims due to its design flexibility.

Following criticism on the sampling scheme used to study the origin of Black (Box 1), the redoubtableBlack-is-Red group genotyped Cyan. Using even sample sizes, they demonstrated that Black is closer to Red (DBlack-Red=0.46) (Fig. 8A), where D is the Euclidean distance between the samples over all three PCs (short distances indicate high similarity). The Black-is-Green school criticized their findings on the grounds that their Cyan samples were biased and their results do not apply to the broad Black cohort. They also reckoned that the even sampling scheme favored Red because Blue is related to Cyan through shared language and customs. The Black-is-Red group responded by enriching their cohort in Cyan and Black (nCyan, nBlack=1000) and provided even more robust evidence that Black is Red (DBlack-Red=0.12) (Fig. 8B). However, the Black-is-Green camp dismissed these findings. Conscious of the effects of admixture, they retained only the most homogeneous Green and Cyan (nGreen, nCyan=33), genotyped new Blue and Black (nBlue, nBlack=400), and analyzed them with the published Red cohort (nRed=100). The Black-is-Green results supported their hypothesis that Black is Green (DBlack-Green=0.27) and that Cyan shared a common origin with Blue (DBlue-Green=0.27) (Fig. 8C) and should thereby be considered an admixed Blue population. Unsurprisingly, the Black-is-Red group claimed that these results were due to the under-representation of Black since when they oversampled Black, PCA supported their findings (Fig. 8A). In response, the Black-is-Green school maintained even sample sizes for Cyan, Blue, and Green (nBlue, nGreen, nCyan=33) and enriched Black and Red (nRed, nBlack=100). Not only did their results (DBlack-Green=0.63

PCA with the primary and mixed color populations. (A) nall=100; nBlack=200, (B) nRed=nGreen=nBlue=100; nBlack=nCyan=500, (C) nRed=100; nGreen=nCyan=33; nBlue=nBlack=400; and (D) nRed=nBlack=100; nGreen=nBlue=nCyan=33; Scatter plots show the top two PCs. The numbers on the grey bars reflect the Euclidean distances between the color populations over all PCs. Colors include Red [1,0,0], Green [0,1,0], Blue [0,0,1], Cyan [0,1,1], and Black [0,0,0].

The question of how analyzing admixed groups with multiple ancestral populations affects the findings for unmixed groups is illustrated through a typical study case in Box 3.

To understand how PCA can be misused to study multiple mixed populations, we will investigate other PCA applications to study AJs. Such analyseshave a thematic intepretation, wherethe clustering of AJsamples is evidence of a sharedLevantine origin, e.g., Refs.12,13, that short distances between AJs and Levantines indicate close genetic relationships in support of a shared Levantine past, e.g., Ref.12, whereas the short distances between AJs and Europeans areevidence of admixture13. Finally,as a rule, the much shorter distances between AJs and the Caucasus or Turkish populations, observed by all recent studies, were ignored12,13,47,48. Bray et al.48 concluded that not only doAJs have a more southern origin but that their alignment with Central Europeans is consistent with migration to this region. In these studies, "short" andbetween received a multitude of interpretations. For example, Gladstein and Hammer's53 PCA plot that showed AJs in the extreme edge of the plot with Bedouins and French in the other edges was interpreted as AJs clustering tightly between European and Middle Eastern populations. The authors interpreted the lack of outliers among AJs (which were never defined) as evidence of common AJ ancestry.

Following the rationale of these studies, it is easy to show how PCA can be orchestrated to yield a multitude origins for AJs. We replicated the observation that AJs are population isolate, i.e., AJs form a distinct group, separated from all other populations (Fig. 9A), and are thereby genetically distinguishable47. We also replicated the most common yet often-ignored observation, that AJs cluster tightly with Caucasus populations (Fig. 9B). We next produced novel results where AJs cluster tightly with Amerindians due to the north Eurasian or Amerindian origins of both groups (Fig. 9C). We can also show that AJs cluster much closer to South Europeans than Levantines (Fig. 9D), and overlap Finns entirely, in solid evidence of AJs ancient Finnish origin (Fig. 9E). Last, we wish to refute our previous finding and show that only half of the AJs are of Finnish origin. The remaining analysis supports the lucrative Levantine origin (Fig. 9F)a discovery touted by all the previous reports though never actually shown. Excitingly enough, the primary PCs of this last Eurasian Finnish-Levantine mixed origin depiction explained the highest amount of variance. An intuitive interpretation of those results is a recent migration of the Finnish AJs to the Levant, where they experienced high admixture with the local Levantine populations that altered their genetic background. These examples demonstrate that PCA plots generate nonsensical results for the same populations and no a posteriori knowledge.

An in-depth study of the origin of AJs using PCA in relation to Africans (Af), Europeans (Eu), East Asians (Ea), Amerindians (Am), Levantines (Le), and South Asians (Sa). (A) nEu=159; nAJ=60; nLe=82, (B) nAf=30; nEu=159; nEa=50; nAJ=60; nLe=60, (C) nAf=30; nEa=583; nAJ=60; nAm=255; (D) nAf=200; nEu=115; nEa=200; nAJ=60; nLe=235; nSa=88, (E) nAf=200; nEu=30; nAJ=400, nLe=80 (F) nAf=200; nEu=30; nAJ=50; nLe=160. Large square indicate insets.

The value of using mixed color populations to study origins prompted new analyses using even (Fig. 10A) and variable sample sizes (Fig. 10BD). Using this novel sampling scheme, the Black-is-Green school reaffirmed that Black is the closest to Green (Fig. 10A, 10C, and 10D)in a series of analyses, but using a different cohort yielded a novel finding that Black is closest to Pink (Fig. 10B).

PCA with the primary and multiple mixed color populations. (A) nall=50, (B) nall=50 or 10, (C,D) nAll=[50, 5, 100, or 25]. Scatter plots show the top two PCs. Colors codes are shown. (E) The difference between the true distances calculated over a 3D plane between every color population pair (shown side by side) from (D) and their Euclidean distances calculated from the top two PCs. Pairs whose PC distances from each other reflect their true 3D distances are shown along the x=y dotted line. One of the largest PCA distortions is the distances between the Red and Green populations (inset). The true Red-Green distance is 1.41 (x-axis), but the PCA distance is 0.5 (y-axis).

The extent to which PCA distances obtained by the top two PCs reflect the true distances among color population pairs is shown in Fig. 10E. PCA distorted the distances between most color populations, but the distortion was uneven among the pairs, and while a minority of the pairs are correctly projected via PCA, most are not. Identifying which pairs are correctly projected is impossible without a priori information. For example, some shades of blue and purple were less biased than similar shades. We thereby show that PCA inferred distances are biased in an unpredicted manner and thereby uninformative for clustering.

Unlike stochasticmodels that possess inherent randomness, PCA is a deterministic process, a property that contributes to its perceived robustness. To explore the behavior of PCA, we tested whether the same computer code can produce similar or different results when the only variable that changes is the standard randomization technique used throughout the paper to generate the individual samples of the color populations (to avoid clutter).

We evaluated two color sets. In the first set, Black was the closest to Yellow (Fig.11A), Purple (Fig.11C), and Cyan (Fig.11D,E). When adding White, in the second set, Black behaved as an outgroup as the distances between the secondary colors largely deviated from the expectation and produced false results (Fig.11DF). These results illustrate the sensitivity of PCA to tiny changes in the dataset, unrelated to the populations or the sample sizes.

Studying the effects of minor sample variation on PCA results using color populations (nall=50). (AC) Analyzing secondary colors and Black. (DE) Analyzing secondary colors, White, and Black. Scatter plots show the top two PCs. Colors include Cyan [0,1,1], Purple [1,0,1], Yellow [1,1,0], White [1,1,0], and Black [0,0,0].

To explore this effect on human populations, we curated a cohort of 16 populations. We carried out PCA on ten random individuals from 15 random populations. We show that these analyses result in spurious and conflicting results (Fig.12). Puerto Ricans, for instance, clustered close to Europeans (A), between Africans and Europeans (B), close to Adygei (C), and close to Europe and Adygei (D). Indians clustered with Mexicans (A, B, and D) or apart from them (C). Mexicans themselves cluster with (A and D) or without (B and C)Africans. Papuans and Russians cluster close (B) or afar (C) from East Asian populations. More robust clustering was observed for East Asians, Caucasians, and Europeans, as well as Africans. However, these were not only indistinguishable from the less robust clustering but also failed to replicate over multiple runs (results not shown). These examples show that PCA results are unpredictable and irreproducible even when 94% of the populations are the same. Note that the proportion of explained variance was similar in all the analyses, demonstrating that it is not an indication of accuracy or robustness.

Studying the effect of sampling on PCA results. A cohort of 16 worldwide populations (see legend) was selected. In each analysis, a random population was excluded. Populations were represented by random samples (n=10). The clusters highlight the most notable differences.

We found that although a deterministic process, PCA behaves unexpectedly, and minor variations can lead toan ensemble of different outputs that appear stochastic. This effect is more substantial when continentalpopulations are excluded from the analysis.

Samples of unknown ancestry or self-reported ancestry are typically identified by applying PCA to a cohort of test samplescombined with reference populations of known ancestry (e.g., 1000 Genomes), e.g., Refs.22,54,55,56. To test whether using PCA to identify the ancestry of an unknown cohort with known samples is feasible, we simulated a large and heterogeneous Cyan population (Fig.13A, circles) of self-reported Blue ancestry. Following a typical GWAS scheme, we carried out PCA for these individuals and seven known and distinct color populations. PCA grouped the Cyanindividuals with Blue and Black individuals (Fig.13B), although none of the Cyanindividuals were Blue or Black (Fig.13A), as a different PCA scheme confirmed (Fig.13C). A casecontrol assignment of this cohort to Blue or Black based on the PCA result (Fig.13B) produced poor matches that reduced the power of the analysis. When repeating the analysis with different reference populations (Fig.13D), the simulated individuals exhibited minimal overlap with Blue, no overlap with Black, and overlapped mostly with the Cyan reference population present this time. We thereby showed that the clustering with Blue and Black is an artifact due to the choice of reference populations. In other words, the introduction of reference populations with mismatched ancestries respective to the unknown samples biases the ancestry inference of the latter.

Evaluating the accuracy of PCA clustering for a heterogeneous test population in a simulation of a GWAS setting. (A) The true distribution of the test Cyan population (n=1000). (B) PCA of the test population with eight even-sized (n=250) samples from reference populations. (C) PCA of the test population with Blue from the previous analysis shows a minimal overlap between the cohorts. (D) PCA of the test population with five even-sized (n=250) samples from reference populations, including Cyan (marked by an arrow). Colors (B) from top to bottom and left to right include: Yellow [1,1,0], light Red [1,0,0.5], Purple [1,0,1], Dark Purple [0.5,0,0.5], Black [0,0,0], dark Green [0,0.5,0], Green [0,1,0], and Blue [1,0,0].

We next asked whether PCA results can group Europeans into homogeneous clusters. Analyzing four European populations yielded 43% homogeneous clusters (Fig.14A). Adding Africans and Asians and then South Asian populations decreased the European cluster homogeneity to 14% and 10%, respectively (Fig.14B,C). Including the 1000 Genome populations, as customarily done, yielded 14% homogeneous clusters (Fig.14D). Although the Europeans remained the same, the addition of other continental populations resulted in a three to four times decrease in the homogeneity of their clusters.

Evaluating the cluster homogeneity of European samples. PCA was applied to the four European populations (Tuscan Italians [TSI], Northern and Western Europeans from Utah [CEU], British [GBR], and Spanish [IBS]) alone (A), together with an African and Asian population (B), as well as South Asian population (C), and finally with all the 1000 Genomes Populations (D). (E) Evaluating the usefulness of PCA-based clustering. The bottom two plots show the sizes of non-homogeneous and homogeneous clusters, and the top three plots show the proportion of individuals in homogeneous clusters. Each plot shows the results for 10 or 20 random African, European, or Asian populations for the same PCs (x-axis).

The number of PCs analyzed in the literature ranges from 2 to, at least, 28035, which raises the question of whether using more PCs increases cluster homogeneity or is another cherry-picking strategy. We calculated the cluster homogeneity for different PCs for either 10 or 20 African (n10=337, n20=912), Asian (n10=331, n20=785), and European (n10=440, n20=935) populations of similar sample sizes (Fig.14E). Even in this favorable setting that included only continental populations, on average, the homogeneous clusters identified using PCA were significantly smaller than the non-homogeneous clusters (Homogeneous=12.5 samples; Non-homogeneous=42.6 samples; Homogeneous=12.5 samples; Non-homogeneous=42.6 samples; KruskalWallis test [nHomogeneous=nNon-homogeneous=238 samples, p=1.951075, Chi-square=338]) and included a minority of the individuals when 20 populations were analyzed. Analyzing higher PCs decreased the size of the homogeneous clusters and increased the size of the non-homogeneous ones. The maximum number of individuals in the homogeneous clusters fluctuated for different populations and sample sizes. Mixing other continental populations with each cohort decreased the homogeneity of the clusters and their sizes (results now shown). Overall, these examples show that PCA is a poor clustering tool, particularly as sample size increases, in agreement with Elhaik and Ryan57, who reported that PCA clusters are neither genetically nor geographical homogeneous and that PCA does not handle admixed individuals well. Note that the cluster homogeneity in this limited setting should not be confused with the amount of variance explained by additional PCs.

To further assess whether PCA clustering represents shared ancestry or biogeography, two of the most common applications of PCA, e.g., Ref.22, we applied PCA to 20 Puerto Ricans (Fig.15) and 300 Europeans. The Puerto Ricans clustered indistinguishably with Europeans (by contrast to Fig.12) using the first two and higher PCs (Fig.15). The Puerto Ricans represented over 6% of the cohort, sufficient to generate a stratification bias in an association study. We tested that by randomly assigning casecontrol labels to the European samples with all the Puerto Ricans as controls. We then generated causal alleles to the evenly-sized cohorts and computed the association before and after PCA adjustment. We repeated the analysis with randomly assigned labels to all the samples. In all our 12 casecontrol analyses, the outcome of the PCA adjustment for 2 and 10 PCs were worse than the unadjusted results, i.e., PCA adjusted results had more false positives, fewer true positives, and weaker p-values than the unadjusted results (Supplementary Text 3).

PCA of20 Puerto Ricans and 300 random Europeans from the 1000 Genomes. The results are shown for various PCs.

We next assessed whether the distance between individuals and populations is a meaningful biological or demographic quantity by studying the relationships between Chinese and Japanese, a question of major interest in the literature58,59. We already applied PCA to Chinese and Japanese, using Europeans as an outgroup (Supplementary Fig. S2.4). The only element that varied in the following analyses was the number of Mexicans as the second outgroup (5, 25, and 50). We found that the proportion of homogeneous Japanese and Chinese clusters dropped from 100% (Fig.16A) to 93.33% (Fig.16B) and 40% (Fig.16C), demonstrating that the genetic distances between Chinese and Japanese depend entirely on the number of Mexicans in the cohort rather than the actual genetic relationships between these populations as one may expect.

The effect of varying the number of MexicanAmerican on the inference of genetic distances between Chinese and Japaneseusing various PCs. We analyzed a fixed number of 135 Han Chinese (CHB), 133 Japanese (JPT), 115 Italians (TSI), and a variable number of Mexicans (MXL), including 5 (left column), 25 (middle column), and 50 (right column) individuals over the top four PCs. We found that the overlap between Chinese and Japanese in PC scatterplots, typically used to infer genomic distances, was unexpectedly conditional on the number of Mexican in the cohort. We noted the meaning of the axes of variation whenever apparent (red). The right column had the same axes of variations as the middle one.

Some authors consider higher PCs informative and advise considering these PCs alongside the first two. In our case, however, these PCs were not only susceptible to bias due to the addition of Mexicans but also exhibited the exact opposite pattern observed by the primary PCs (e.g., Fig.16GI). It has also been suggested that in datasets with ancestry differences between samples, axes of variation often have a geographic interpretation10. Accordingly, the addition of Mexicans altered the order of axes of variation between the cases, making the analysis of additional PCs valuable. We demonstrate that this is not always the case. Excepting PC1, over 60% of the axes had no geographical interpretation or an incorrect one. An a priori knowledge of the current distribution of the population was essential to differentiate these cases. The addition of the first 20 Mexicans replaced the second axis of variation (initially undefined) with a third axis (Eurasia-America) in the middle and right columns and resulted in a minor decline of~5% of the homogeneous clusters. Adding 25 Mexicans to the second cohort did not affect the axes, but the proportion of homogeneous clusters declined by 66%. The axes changes were unexpected and altered the interpretation of PCA results. Such changes were not detectable without an a priori knolwedge.

These results demonstrate that (1) the observable distances (and thereby clusters) between populations inferred from PCA plots (Figs.14, 15, 16) are artifacts of the cohort and do not provide meaningful biological or historical information, (2) that distances betewen samples can be easily manipulated by the experimenter in a way that produces unpredictable results, (3) that considering higher PCs produces conflicting patterns, which are difficult to reconcile and interpret, and (4) that our extensive exploration of PCA solutions to Chinese and Japanese relationships using 18 scatterplots and four PCs produced no insight. It is easy to see that the multitude of conflicting results, allows the experimenter to select the favorable solution that reflects their a priori knowledge.

Incorporating precalculated PCA is done by projecting the PCA results calculated for the first dataset onto the second one, e.g., Ref.17. Here, we tested the accuracy of this approach by projecting one or more color populations onto precalculated color populations that may or may not match the projected ones. The accuracy of the results was dependent on the identity of the populations of the two cohorts. When the same populations were analyzed, they overlapped (Fig.17A), but when unique populations were found in the two datasets, PCA created misleading matches (Figs.17BD). In the latter case, and when the sample sizes were uneven (Fig.17C), the projected samples formed clusters with the wrong populations, and their positioning in the plot was incorrect. Overall, we found that PCA projections are unreliable and misleading, with correct outcomes indistinguishable from incorrect ones.

Examining the accuracy of PCA projections. The PCA results of one dataset (circles) were projected onto another (squares). In (A), testing the case of varying sample sizes between the first (nRed=200, nGreen=10, nBlue=200, nPurple=10) and second (nRed=200, nGreen=200, nBlue=10, nPurple=10) datasets, where in the second dataset, colors varied a little (e.g., [1,0,0][1,0.1,0.1]). In (BD), the sample size varied (10n300) for both datasets. Colors include Red [1,0,0], Green [0,1,0], light Green [1,0.2,1], Cyan [0,1,1], Blue [0,0,1], Purple [1,0,1], Yellow [1,1,0], Grey [0.5,0.5,0.5], White [1,1,1], and Black [0,0,0].

To evaluate the reliability of projections for human populations, we tested whether the projected populations cluster with their closest groups and to what extent these results can be manipulated. We found that populations can be shown to correctly align with continental populations when the base (or test) populations and the projected populations are very similar (Fig.18A), which gives us confidence in the accuracy of PCA projections. However, even in the simplest scenario of using three continental populations, it is unclear how to interpret the overlap between the base and projected populations since the Spanish would not be considered genetically closer to Finns than Italians, as suggested by PCA. In another simple scenario, where Europeans are projected onto other Europeans, distinct populations like AJs, Iberians, French, CEU, and British overlap entirely (Fig.18B), whereas Finns and Italians were separate. Not only do the results share no apparent resemblance to the geographical distribution, but they also produce conflicting information as to the genetic distances between these populationstwo properties that PCAenthusiastics claimit represents. Adding more populations, even if only to the projected populations, contributes to further distortions with previously distinct populations (Fig.18B) now clustering (Fig.18C). In a different dataset, projecting Japanese onto a base dataset of Africans and Europeans places them as an admixed African-European population. The projected Finns cluster with other Europeans (Fig.18D), at odds with the previous results (Fig.18B) that singled them out.

PCA projections of populations (italic and black star inside the shape) onto base populations with even-sized sample (n=50, unless noted otherwise) (regular font). In (A) nprojected=100, (B) nprojected=50, (C) nprojected=20, (D) nprojected=100, (E) nprojected=80 and nprojected=100, and (F) 80nprojected100 and 12nprojected478.

To test the behavior of PCA when projecting populations different from the base populations, we projected Chinese, Finns, Indians, and AJs onto Levantine and two European populations (Fig.18E). The results imply that the Chinese and AJs are of an Indian origin originating from a European-Levantine mix. Replacing Levantines with Africans does not stabilize the projected results (Fig.18F). Now the projected Chinese and Japanese overlap, and AJs cluster with Iranians.

Overall, our results show that it is unfeasible to rely on PCA projections, particularly in studies involving different populations, as is commonly done. Even when the projected populations are identical to the base ones, the base and projected populations may or may not overlap.

PCA is the primary tool in paleogenomics, where ancient samples are initially identified based on their clustering with modern or other ancient samples. Here, a wide variety of strategies is employed. In some studies, ancient and modern samples are combined60. In other studies, PCA is performed separately for each ancient individual and particular reference samples, and the PC loadings are combined61. Some authors projected present-day human populations onto the top two principal components defined by ancient hominins (and non-humans)62. The most common strategy is to project ancient DNA onto the top two principal components defined by modern-day populations14. Here, we will investigate the accuracy of this strategy.

Since ancient populations show more genetic diversity than modern ones14, we defined ancient colors (a) as brighter colors whose allele frequency is 0.95 with an SD of 0.05 and modern colors (m) as darker colors whose allele frequency is 0.6 with an SD of 0.02. Two approaches were used in analyzing the two datasets: calculating PCA separately for the two datasets and presenting the results jointly (Fig.19A,B), and projecting the PCA results of the ancient populations onto the modern ones (Fig.19C,D). In both cases, meaningful results would show the ancient colors clustering close to their modern counterparts in distances corresponding to their true distances.

Merging PCA of ancient (circles) and modern (squares) color populations using two approaches. First, PCA is calculated separately on the two datasets, and the results are plotted together (A,B). Second, PCA results of ancient populations are projected onto the PCs of the modern ones (C,D). In (A), even-sized samples from ancient (n=25) and modern (n=75) color populations are used. In (B), different-sized samples from ancient (10n25) and modern (10n75) populations are used. In (C) and (D), different-sized samples from ancient (10n75) are used alongside even-sized samples from modern populations: (C) (n=15) and (D) n=25. Colors include Red [1,0,0], dark Red [0.6,0,0], Green [0,1,0], dark Green [0,0.6,0], Blue [0,0,1], dark Blue [0,0,0.6], light Cyan [0,0.6,0.6], light Yellow [0.6,0.6,0], light Purple [0.6,0,0.6], and Black [0,0,0].

These are indeed the results of PCA when even-sized modern and ancient samples from color populations are analyzed and the color pallett isbalanced (Fig.19A). In the more realistic scenario where the color pallet is imbalanced and sample sizes differ, PCA produced incorrect results where ancient Green (aGreen) clustered with modern Yellow (mYellow) away from its closest mGreen that clustered close to aRed. mPurple appeared as 4-ways mixed of aRed, aBlue, mCyan, and mDark Blue. Instead of being at the center (Fig.19A), Black became an outgroup and its distances to the other colors were distorted (Fig.19B). Projecting ancient colors onto modern onesalso highly misrepresented the relationships among the ancient samples as aRed overlapped with aBlue or aGreen, mYellow appeared closer to mCyan or aRed, and the outgroups continuously changed (Fig.19C,D). Note that the first two PCs of the last results explained most of the variance (89%) of all anlyses.

Recently, Lazaridis et al.14 projected ancient Eurasians onto modern-day Eurasians and reported that ancient samples from Israel clustered at one end of the Near Eastern cline and ancient Iranians at the other, close to modern-day Jews. Insights from the positions of the ancient populations were then used in their admixture modeling that supposedly confirmed the PCA results. To test whether the authors inferences were correct and to what extent those PCA results are unique, we used similar modern and ancient populations to replicate the results of Lazaridis et al.14 (Fig.20A). By adding the modern-day populations that Lazaridis et al.14 omitted, we found that the ancient Levantines cluster with Turks (Fig.20B), Caucasians (Fig.20C), Iranians (Fig.20D), Russians (Fig.20E), and Pakistani (Fig.20F) populations. The overlap between the ancient Levantines and other populations also varied widely, whereas they cluster with ancient Iranians and Anatolians, Caucasians, or alone, as a population isolate. Moreover, the remaining ancient populations exhibited conflicting results inconsistent with our understanding of their origins. Mesolithic and Neolithic Swedes, for instance, clustered with modern Eastern Europeans (Fig.20AC) or remotely from them (Fig.20DF). These examples show the wide variety of results and interpretations possible to generate with ancient populations projected onto modern ones. Lazaridis et al.s14 results are neither the only possible onesnor do they explain the most variation. It is difficult to justify Lazaridis et al.s14 preference for the first outcome where the first two components explained only 1.35% of the variation (in our replication analysis. Lazaridis et al. omitted the proportion of explained variation) (Fig.20A), compared to all the alternative outcomes that explained a much larger portion of the variation (1.926.06%).

PCA of 65 ancient Palaeolithic, Mesolithic, Chalcolithic, and Neolithic from Iran (12), Israel (16), the Caucasus (7), Romania (10), Scandinavia (15), and Central Europe (5) (colorful shapes) projected onto modern-day populations of various sample sizes (grey dots, black labels). The full population labels are shown in Supplementary Fig. S8. In addition to the modern-day populations used in (A), the following subfigures also include (B) Han Chinese, (C) Pakistani (Punjabi), (D) additional Russians, (E) Pakistani (Punjabi) and additional Russians, and (F) Pakistani (Punjabi), additional Russians, Han Chinese, and Mexicans. The ancient samples remained the same in all the analyses. In each plot (AF), the ancient Levantines cluster with different modern-day populations.

We note that for high dimensionality data where markers are in high LD, projected samples tend to shrink, i.e., move towards the center of the plot. Corrections to this phenomenon have been proposed in the literature, e.g., Ref.63. This phenomenon does not affect our datasets, which are very small (Fig.19) or LD pruned (Fig.20).

The effect of marker choice on PCA results received little attention in the literature. Although PCA is routinely applied to different SNP sets, the PCs are typically deemed comparable. In forensic applications, that typically employ 100300 markers, this is a major problem. To evaluate the effect of various markers on PCA outcomes, it is unfeasible to use our color model, although it can be used to study the effects of missing data and noise, which are common in genomic datasets and reflect the biological properties of different marker types in capturing the population structure. Remarkably, the addition of 50% (Fig.21A) and even 90% missingness (Fig.21B) allowed recovering the original population structure. The structure decayed when random noise was added to the latter dataset (Fig.21C). To further explore the effect of noise, we added random markers to the dataset. An addition of 10% of noisy markers increased the dataset's disparity, but it still retained the original structure (Fig.21D). Interestingly, even adding 100% noisy markers allowed identifying the original structure's key features (Fig.21E). Only when adding 1000%, noisy markers did the original structure disappear (Fig.21F). Note that the introduction of noise has also sliced the percent of variation explained by the PCs. These results highlight the importance of using ancestry informative markers (AIMs) to uncover the true structure of the dataset and accounting for disruptive markers.

Testing the effects of missingness and noise in a PCA of six fixed-size (n=50) samples from color populations. The top plots show the effect of missingness alone or combined with noise: (A) 50% missingness, (B) 90% missingness, and (C) 90% missingness and low-level random noise in all the markers. The bottom plots test the effect of noise when added to the original markers in the above plots using: (D) 30 random markers, (E) 300 random markers, and (F) 3000 random markers. Colors include Red [1,0,0], Green [0,1,0], Blue [0,0,1], Cyan [0,1,1], Yellow [1,1,0], and Black [0,0,0].

To evaluate the extent to which marker types represent the population structure, we studied the relationships between UK British and other Europeans (Italians and Iberians) using different types of 30,000 SNPs, a number of similar magnitude to the number of SNPs analyzed by some groups64,65. According to the full SNP set, the British do not overlap with Europeans (Fig.22A). However, coding SNPs show considerable overlap (Fig.22B) compared with intronic SNPs (Fig.22C). Protein coding SNPs, RNA molecules, and upstream or downstream SNPs (Fig.22DF, respectively) also show small overlap. The identification of outliers, already a subjective measure, may also differ based on the proportions of each marker type. These results not only illustrate how the choice of markers and populations profoundly affect PCA results but also the difficulties in recovering the population structure in exome datasets. Overall, different marker types represent the population structure differently.

PCA of Tuscany Italians (n=115), British (n=105), and Iberians (n=150) across all markers (p~129,000) (A) and different marker types (p~30,000): (B) coding SNPs, (C) intronic SNPs, (D) protein-coding SNPs, (E) RNA molecules, and (F) upstream and downstream SNPs. Convex hull was used to generate the European cluster.

PCA is used to infer the ancestry of individuals for various purposes, however a minimal sample size of one, may be even more subjected to biases than in population studies. We found that such biases can occur when individuals with Green (Fig.23A) and Yellow (Fig.23B) ancestries clustered near admixed Cyan individuals and Orange, rather than with Greens or by themselves, respectively. One Grey individual clustered with Cyan (Fig.23C) when it is the only available population, much like a Blue sample clustered with Green samples (Figs. 23D).

Inferring single individual ancestries using reference individuals. In (A) Using even-sized samples from reference populations (n=37): Red [1,0,0], Green [0,1,0], bright Cyan [0, 0.9, 0.8], dark Cyan [0, 0.9, 0.6], heterogeneous darker Cyan [0, 0.9, 0.4] with high standard deviation (0.25) with a light Green test individual [0, 0.5, 0]. In (B) Using the same reference populations as in (A) with uneven-sizes: Red (n=15), Green (n=15), bright Cyan (n=100), dark Cyan (n=15), heterogeneous darker Cyan (n=100), with a Yellow test indiviaul (1,1,0). In (C) A heterogeneous Cyan population [0, 1, 1] (n=300) with high standard deviation (0.25) and a Grey test individual (0.5, 0.5, 0.5). In (D) Red [1,0,0] (n=10), Green [0,1,0] (n=10), a heterogeneous population [1, 1, 0.5] (n=200) and a Blue test individual (0,0,1).

Arguably, one of the most famous cases of personalancestral inference occurred during the 2020 US presidential primaries when a candidate published the outcome of their genetic test undertaken by Carlos Bustamante that tested their Native American ancestry (https://elizabethwarren.com/wp-content/uploads/2018/10/Bustamante_Report_2018.pdf). Analyzing 764,958 SNPs, Bustamante sought to test the existence of Native American ancestry using populations from the 1000 Genomes Project and Amerindians. RFMix66 was used to identify Native American ancestry segments and PCA, elevated to be a machine learning technique, to verify that ancestry independently of RFMix. The longest of five genetic segments, judged to be of Native American origin, was analyzed using PCA and reported to be clearly distinct from segments of European ancestry and strongly associated with Native American ancestry as it clustered with Native Americans distinctly from Europeans and Africans (Fig.1 in their report) and between Native American samples (Fig.2 in their report). Bustamante concluded that While the vast majority of the individuals ancestry is European, the results strongly support the existence of an unadmixed Native American ancestor in the individuals pedigree, likely in the range of 610 generations ago.

We have already shown that AJs (Fig.9C) and Pakistanis (Fig.14D) can cluster with Native Americans. With the candidates DNA unavailable (and their specific European ancestry undisclosed), we tested whether the two PCA patterns observed by Bustamante can be reproduced for modern-day Eurasians without any reported Native American ancestry (Pakistani, Iranian, Even Russian, and Moscow Russian) (Figs.24AD, respectively).

Evaluation of Native American ancestry for four Eurasians. (A) Using even-sample size (n=37) for Africans, Mexican-Americans, British, Puerto Ricans, Colombians, and a Pakistani. (B) Using uneven-sample sizes, for Africans (n=100), Mexican-Americans (n=20), British (n=50), Puerto Ricans (n=89), Colombians (n=89), and an Iranian. (C) Analyzing awhole-Amerindian cohort of Colombian (n=93), Mexican-Americans (n=117), Peruvian (n=75), Puerto Ricans (n=102), and an Even Russian. (D) Using uneven-sample sizes, for Africans (n=100), Mexican-Americans (n=53), British (n=20), Puerto Ricans (n=30), Colombians (n=89), and a Moscow Russian. All the samples were randomly selected.

These analyses show that the experimenter can easily generate desired patterns to support personalancestral claims, making PCA an unreliable and misleading tool to infer personalancestry. We further question the accuracy of Bustamantes report, provided the biased reference population panel used by RFMixto infer the DNA segments with the alleged Amerindian origin, which excluded East European and North Eurasian populations. We draw no conclusions about the candidates ancestry.

Continue reading here:
Principal Component Analyses (PCA)-based findings in population genetic studies are highly biased and must be reevaluated | Scientific Reports -...

Posted in Genetics | Comments Off on Principal Component Analyses (PCA)-based findings in population genetic studies are highly biased and must be reevaluated | Scientific Reports -…

Is COVID-19 Loss of Smell Genetic? What Research Shows – Healthline

Posted: August 30, 2022 at 3:01 am

COVID-19 is a respiratory disease caused by an infection with the coronavirus SARS-CoV-2.

Since its discovery in late 2019, the coronavirus has led to more than 6.45 million deaths worldwide and more than 1 million deaths in the United States.

COVID-19 can lead to severe or life threatening illness, especially in older adults, people who are not vaccinated, and people with weakened immune systems. Most people with COVID-19 develop mild symptoms.

Loss of smell or taste are two of the most-reported symptoms. Other common symptoms of COVID-19 include:

Research suggests that people with certain genes may develop loss of taste or smell more often. Scientists are continuing to examine this association. Read on to learn what we know so far about the link.

Loss of smell and loss of taste are commonly reported COVID-19 symptoms. Researchers are continuing to examine why some people with COVID-19 develop these symptoms while others dont. Recent evidence suggests genetics may play a role.

Among 32,142 people with COVID-19 in a 2021 review of studies, 38.2% of them developed loss of smell while 36.6% developed loss of taste.

In a 2022 study, researchers collected data on COVID-19-related loss of smell or taste from surveys from 69,841 people. Researchers found that 68% of people reported one of these symptoms.

Researchers found that certain location variants of the UGT2A1 and UGT2A2 genes expressed in the olfactory epithelium were associated with COVID-19-related loss of smell. Your olfactory epithelium is a thin layer of tissue along the roof of your nose that helps you smell.

These two genes play a role in metabolizing substances called odorants that trigger your sense of smell. But its not clear exactly how and why these genes influence COVID-19-related smell loss.

Several possible reasons people with COVID-19 develop loss of smell have been hypothesized, but the exact cause isnt clear. Possible mechanisms theorized to contribute include:

Experimental evidence suggests damage to the cilia in your nose and olfactory epithelium contribute to loss of smell in people with COVID-19, but not infection of the nerves in your brain that help you smell. Cilia are tiny hairs that help clear away mucus.

This evidence also suggests the coronavirus enters and accumulates in olfactory support cells through angiotensin converting enzyme 2 and transmembrane protease serine 2. Dysfunction of these cells can impair your ability to smell.

In a 2021 review of 45 studies including 42,120 people with COVID-19, researchers found that people severely ill or hospitalized for COVID-19 had a lower chance of experiencing loss of smell than those who were not severely ill or hospitalized.

In the 2022 study mentioned above, researchers found:

Learn more about who is most likely to lose their sense of smell and taste.

In a 2021 study involving 67 people with COVID-19, 74.6% recovered their sense of smell an average of 60 days after developing COVID-19. The remaining 25.4% had persistent smell loss that lingered beyond 60 days.

Another 2021 study found that 96.1% of a group of 97 people with COVID-19-related loss of smell recovered by 12 months, which was about 10% more than had recovered at 6 months.

In a 2021 review of 17 studies, researchers found that the average duration of smell and taste disorders was 7.5 days, plus or minus 3.2 days, in a group of 79 people with COVID-19. Meanwhile, 40% of people recovered completely within 7.4 days, plus or minus 2.3 days.

Learn more about how long people with COVID-19 lose their sense of smell.

Most people regain their sense of smell or taste within a couple of months of developing COVID-19. However, a small number of people have lingering effects that can last for a year or longer.

If your smell doesnt return, your doctor may recommend olfactory training.

Olfactory training involves repeatedly sniffing scents for 20 seconds each at least twice a day for 3 months or more. Common scents include lemon, rose, cloves, and eucalyptus.

Research suggests that olfactory training can be an effective treatment for COVID-19-related smell loss.

Some doctors may recommend treatments like steroids and high doses of omega-3 fatty acids. These have been found to be effective for treating smell loss from nonviral causes.

One small 2020 study found evidence that omega-3s helped protect the sense of smell in people undergoing nasal surgery. The ability of omega-3s to treat COVID-19-related smell loss remains theoretical.

Additionally, intranasal vitamin A has also been recommended as a possible therapy that may help with olfactory regrowth.

Visit your doctor if you or your child have lingering symptoms that persist about 4 weeks or longer after you develop COVID-19.

Your doctor can suggest tests that may identify the root cause of your symptoms and rule out other conditions that may be contributing.

Loss of taste and smell are commonly reported symptoms of COVID-19. Researchers are still trying to understand why some people develop these symptoms and others dont. Current evidence suggests genetics may contribute.

In particular, researchers have identified UGT2A1 and UGT2A2 as genes linked to COVID-19-related smell loss. More research is needed to understand exactly what role these genes play.

More here:
Is COVID-19 Loss of Smell Genetic? What Research Shows - Healthline

Posted in Genetics | Comments Off on Is COVID-19 Loss of Smell Genetic? What Research Shows – Healthline

You’re in control: Exercise outweighs genetics when it comes to longer life – Study Finds

Posted: August 30, 2022 at 3:01 am

SAN DIEGO If living into your 90s seems to run in the family, dont just assume that means you will too.Our genetics make us who we are, but new research from the University of California, San Diego finds exercise trumps genes when it comes to promoting a longer life.

You dont need a medical degree to know that forgoing physical activity in favor of stagnation isnt the wisest choice for your health and longevity. But, certain people are genetically predisposed to live longer than others. The research team at UCSD set out to determine if such individuals dont have to move quite as much as the rest of us to live just as long.

The goal of this research was to understand whether associations between physical activity and sedentary time with death varied based on different levels of genetic predisposition for longevity, says lead study author Alexander Posis, M.P.H., a fourth-year doctoral student in the San Diego State University/UC San Diego Joint Doctoral Program in Public Health, in a university release.

This research project began a decade ago. In 2012, as part of the Womens Health Initiative Objective Physical Activity and Cardiovascular Health study (OPACH), study authors began keeping track of the physical activity habits among 5,446 older U.S. women (ages 63 or older). Subjects were tracked up until 2020, and wore a research-grade accelerometer for up to seven days. That device measured how much time they spent moving, the intensity of that physical activity, and their usual amount of sedentary time.

Sure enough, higher levels of light physical activity and moderate-to-vigorous physical activity were associated with a lower risk of dying during the tracking period. Additionally, more time spent sedentary was associated with a higher risk of mortality. Importantly, this observed connection between exercise and a longer life remained consistent even among women determined to have different levels of genetic predisposition for longevity.

Our study showed that, even if you arent likely to live long based on your genes, you can still extend your lifespan by engaging in positive lifestyle behaviors such as regular exercise and sitting less, explains senior study author Aladdin H. Shadyab, Ph.D., assistant professor at the Herbert Wertheim School of Public Health and Human Longevity Science at UC San Diego. Conversely, even if your genes predispose you to a long life, remaining physically active is still important to achieve longevity.

In conclusion, study authors recommend that older women engage in physical activity of any intensity as regularly as possible. Doing so will lower the risk of both various diseases and premature death.

The study is published in the Journal of Aging and Physical Activity.

Read more:
You're in control: Exercise outweighs genetics when it comes to longer life - Study Finds

Posted in Genetics | Comments Off on You’re in control: Exercise outweighs genetics when it comes to longer life – Study Finds

An international team sets out to cure genetic heart diseases with one shot – Freethink

Posted: August 30, 2022 at 3:01 am

Armed with a 30 million grant from the British Heart Foundation, an international team of researchers from the UK, US, and Singapore is setting their sights on curing forms of genetic heart disease using gene therapy.

Called the CureHeart Project, the team which includes researchers from Oxford, Harvard, Singapores National Heart Research Institute, and pharma multinational Bristol Myers Squibb will develop therapies for inherited heart muscle conditions, which impact millions and can cause sudden death, including in young people.

They plan to tackle the problem using two types of targeted techniques, called base editing and prime editing.

An international team of researchers wants to develop a one-shot cure for inherited heart muscle conditions.

Many of the mutations seen in these patients come down to one fateful letter in their DNA code, Christine Seidman, professor of medicine and genetics at Harvard Medical School and co-lead of CureHeart, told The Guardian.

That has raised the possibility that we could alter that one single letter and restore the code so that it is now making a normal gene, with normal function, Seidman said.

The teams work is building on successful demonstrations in animals.

Our goals are to fix the hearts, to stabilise them where they are and perhaps to revert them back to more normal function, Seidman said.

Fixing genetic heart disease: Inherited heart muscle diseases cause abnormalities in the heart, which are passed on through families.

Many different mutations can cause them, but in total, they affect one out of every 250 people around the world, Hugh Watkins, CureHearts lead investigator and the director of Oxfords British Heart Foundation Centre of Research Excellence, told The Guardian.

People of any age can fall victim to sudden heart failure and death, and there is generally a 50/50 chance of passing the problem along to their children.

But decades of genetic research and recent innovations in gene therapy have researchers believing that gene editing may be the answer and even, eventually, the cure.

After 30 years of research, we have discovered many of the genes and specific genetic faults responsible for different cardiomyopathies, and how they work, Watkins said.

Inherited heart muscle conditions impact millions of people, and can cause sudden death.

By using prime and base editing very precise tools for editing DNA the team hopes to develop an injectable cure to repair faulty heart genes, the British Heart Foundation said in a release.

We believe that we will have a gene therapy ready to start testing in clinical trials in the next five years, Watkins told The Guardian.

According to CureHeart, their genetic goals are twofold.

When the cause is a fault in one copy of a gene, which stops the healthy copy from working, they want to switch off the faulty copy; their second approach will be to edit the broken gene sequence itself, to correct it. Theyve demonstrated both methods in mouse models.

Delivering cures: To achieve those goals, the team is turning to two different precision gene editing techniques: prime editing and base editing.

Both enable researchers to edit DNA strands without completely slicing through them (unlike the earlier CRISPR techniques). Prime editing allows researchers to insert or remove certain parts of the genome more precisely, with less collateral damage and fewer errors.

Prime editors offer more targeting flexibility and greater editing precision, Broad Institute chemist David Liu told Science.

They plan to tackle the problem using two types of targeted genetic techniques, called base editing and prime editing.

Base editing which, Science reported, Lius lab invented involves even smaller edits, engineering single letters in the code.

We may be able to deliver these therapies in advance of disease, in individuals we know from genetic testing are at extraordinary risk of having disease development and progressing to heart failure, Seidman told The Guardian.

Never before have we been able to deliver cures, and that is what our project is about. We know we can do it and we aim to get started.

Wed love to hear from you! If you have a comment about this article or if you have a tip for a future Freethink story, please email us at [emailprotected]

Visit link:
An international team sets out to cure genetic heart diseases with one shot - Freethink

Posted in Genetics | Comments Off on An international team sets out to cure genetic heart diseases with one shot – Freethink

Yale Study Suggests That Evolution Can Be Predicted – SciTechDaily

Posted: August 30, 2022 at 3:01 am

Evolution has long been thought to be random, however, a recent study suggests differently.

Evolution has long been thought of as a relatively random process, with species features being formed by random mutations and environmental factors and thus largely unpredictable.

But an international team of scientists headed by researchers from Yale University and Columbia University discovered that a specific plant lineage independently developed three similar leaf types repeatedly in mountainous places scattered across the Neotropics.

The research revealed the first examples in plants of replicated radiation, which is the repeated development of similar forms in different regions. This discovery raises the possibility that evolution is not necessarily such a random process and can be anticipated.

The study was recently published in the journal Nature Ecology & Evolution.

Similar leaf types evolved independently in three species of plants found in cloud forests of Oaxaca, Mexico, and three species of plants in a similar environment in Chiapas, Mexico. This example of parallel evolution is one of several found by Yale-led scientists and suggests that evolution may be predictable. Credit: Yale University

The findings demonstrate how predictable evolution can actually be, with organismal development and natural selection combining to produce the same forms again and again under certain circumstances, said Yales Michael Donoghue, Sterling Professor Emeritus of Ecology & Evolutionary Biology and co-corresponding author. Maybe evolutionary biology can become much more of a predictive science than we ever imagined in the past.

The research team examinedthe genetics and morphology of the Viburnum plant lineage, a genus of flowering plants that started to spread into Central and South America from Mexico around 10 million years ago. Donoghue conducted research on this plant group for his Ph.D. dissertation at Harvard 40 years ago. At the time, he advocated an alternate theory according to which large, hair-covered leaves and small, smooth leaves both evolved early in the history of the group and later migrated separately, being scattered by birds, through the different mountain ranges.

However, the new genetic analyses presented in the study demonstrate that the 2 different leaf types evolved separately and simultaneously in each of many mountain regions.

I came to the wrong conclusion because I lacked the relevant genomic data back in the 1970s, Donoghue said.

The team found that a very similar set of leaf types evolved in nine of the 11 regions studied. However, the full array of leaf types may have yet to evolve in places where Viburnum has only more recently migrated. For instance, the mountains of Bolivia lack the large hairy leaf types found in other wetter areas with little sunshine in the cloud forest in Mexico, Central America, and northern South America.

These plants arrived in Bolivia less than a million years ago, so we predict that the large, hairy leaf form will eventually evolve in Bolivia as well, Donoghue said.

Several examples of replicated radiation have been found in animals, such as Anolis lizards in the Caribbean. In that case, the same set of body forms, or ectomorphs, evolved independently on several different islands. With a plant example now in hand, evolutionary biologists will try to discover the general circumstances under which solid predictions can be made about evolutionary trajectories.

This collaborative work, spanning decades, has revealed a wonderful new system to study evolutionary adaptation, said Ericka Edwards, professor of ecology and evolutionary biology at Yale and co-corresponding author of the paper. Now that we have established the pattern, our next challenges are to better understand the functional significance of these leaf types and the underlying genetic architecture that enables their repeated emergence.

Reference: Replicated radiation of a plant clade along a cloud forest archipelago by Michael J. Donoghue, Deren A. R. Eaton, Carlos A. Maya-Lastra, Michael J. Landis, Patrick W. Sweeney, Mark E. Olson, N. Ival Cacho, Morgan K. Moeglein, Jordan R. Gardner, Nora M. Heaphy, Matiss Castorena, Al Segovia Rivas, Wendy L. Clement, and Erika J. Edwards, 18 July 2022, Nature Ecology & Evolution.DOI: 10.1038/s41559-022-01823-x

View post:
Yale Study Suggests That Evolution Can Be Predicted - SciTechDaily

Posted in Genetics | Comments Off on Yale Study Suggests That Evolution Can Be Predicted – SciTechDaily

Olufunmilayo I. Olopade, MD: Cutting Into Breast Cancer Disparities With Genetic Testing – Everyday Health

Posted: August 30, 2022 at 3:01 am

Where some people see race, gender, and ZIP code as drivers of cancer risk, Olufunmilayo (Funmi) I. Olopade, MD, also sees DNA, RNA, and alleles the stuff of genes and genetic ancestry.

Dr. Olopades work revolves around the intersection of genetics, breast cancer, and racial health disparities. Her research on aggressive breast cancers in young Black African and Black American women has revealed variants of genetic mutations that raise risk for breast cancer and link these two communities.

The Walter L. Palmer Distinguished Service Professor of Medicine and Human Genetics and director of the Center for Clinical Cancer Genetics and Global Health at the University of Chicago Medicine, Olopade earner her MD from the University of Ibadan in Nigeria in 1980. She joined the University of Chicago faculty in 1986.

Her work on cancer risk assessment, prevention, and treatment garnered the Distinguished Clinical Scientist Award of the Doris Duke Charitable Foundation in 2000, a MacArthur Genius Fellowship in 2005, and the 2017 Mendel Medal Lecture at Villanova University.

Today, Olopade continues to build on her work by showing other researchers and clinicians how to explore ancestry-specific genetic variants that lead to breast cancer, and how to use that knowledge to tailor prevention efforts and treatment to each persons needs.

As part of Closing the Cancer Gap, a continuing series on cancer disparities, the world-renowned expert explains her quest to harness heredity and realize the promise of precision medicine for everyone, whether in Nigeria or on the South Side of Chicago.

This interview has been edited for length and clarity.

Everyday Health:You were the first person to link a mutation in the BRCA gene, known to increase risk for breast cancer, in Nigerian women to BRCA mutations in Black American women of African descent. What led to that revelation?

Olufunmilayo I. Olopade:Originally, I wasnt focused on breast cancer. I was in Chicago studying genetics and looking at lymphoma (cancer of the lymphatic system). But then I saw so many young African American women seeking bone marrow transplants because they were facing advanced breast cancers. Some were only in their twenties and came from families with a history of the disease.

I began to seek out the stories of these young women and of others, including the namesake of the Susan G. Komen Foundation (a leading organization funding breast cancer research and awareness globally). Her personal journey and those of the many women who helped the disease gain visibility were intriguing.

Then I went back to Africa and saw young women crowded into a hospital waiting room, desperately sick with advanced breast cancers. I wondered whether we could link our knowledge about the genetic basis of the aggressive breast cancers in American women to these women from Africa and of African ancestry. I felt there was an imperative here, because these fast-growing cancers, called triple-negative, contribute to a 41 percent greater risk of African American women dying from breast cancer compared with their white counterparts.

Ten to 20 percent of all breast cancers in the United States are triple-negative. These cancers are harder to control because they lack the three most common hormone receptors (proteins inside and on the surface of cells that receive messages telling cells what to do). Since many breast cancer therapies target those three receptors, we must look at other options when treating cases of triple-negative.

EH: So, the triple-negative work propelled you into studying breast cancer and genetic ancestry?

OIO: After I launched the University of Chicago Cancer Risk Clinic in 1992, my team and I spent years studying genetics and learning how to identify women at the highest risk of breast cancer. We gathered findings from a large geographical area of Africa and compared them with results found in African Americans in Chicago.

Thats how we confirmed that this specific kind of breast cancer, which shared recurrent BRCA1 (breast cancer 1) mutations, existed in extended African American families with histories of breast cancer and in Africans.

As we continued to grow our knowledge about genetics, we marked the 30th anniversary of the clinics founding in July 2022 with a name change, from the Cancer Risk Clinic to the Cancer Prevention Clinic.

The switch reflects our move beyond fundamental biology understanding how the disease works to using genetics to allow early preventive measures, while, hopefully, maintaining a focus on equity in the medical system. By that I mean ensuring that underserved and underrepresented communities are part of our studies and clinical trials, and that they have access to the genetic screening and counseling too often denied them.

EH: The American Association for Cancer Research 2022 Disparities Report notes that breast cancer is the most prevalent form of cancer among Black American women and predicts that 36,260 new cases will be diagnosed in 2022. Since BRCA genes are relatively rare, what other factors may be contributing to the large case numbers?

OIO:One of the main causes was apparent almost immediately when I first came to Chicago; the presence of two cities.

When I arrived from Nigeria in 1986, I couldnt believe the level of segregation. There were food deserts and medical deserts and insufficiencies in the health system in some South Side and West Side neighborhoods with predominantly African American residents.

There were so few pharmacists in some areas that people couldnt get the medications they needed and would run out. And the health infrastructure was so deficient that it was extremely difficult for the most vulnerable Chicagoans to stay healthy. To my surprise, this was happening in the most well-resourced and blessed country in the world.

Olufunmilayo I. Olopade, MD

Our team was able to bring in many of these people for screening. But if they needed follow-up and treatment, it became tough for them. Many had to drop out because of other issues a lack of transportation, for example, no time off for medical appointments, being a family members caregiver, as well as their inability to pay or a lack of insurance.

Unfortunately, the healthcare system is now reckoning with the general inattention to diseases that affect certain populations. Society has fragmented us into healthcare haves and have-nots.

EH: How can we improve the outcomes for underserved communities while benefiting everyone?

OIO: We have to find a way to get genetic testing done for everyone so that we can fully understand individuals risks and respond accordingly. And when someone has a greater chance of developing the disease, we need to find a way to secure a breast MRI (magnetic resonance imaging), which can pick up cancer long before a mammogram can.

Assessing risk can also help us determine whether we can and should use one of the three approved drugs shown effective in clinical trials at reducing cancer risk. Some of the answers may come from a study now underway, called the WISDOM project (Women Informed to Screen Depending on Measures of Risk), which compares the effectiveness of two approved screening approaches: annual mammograms starting at age 40 for all women versus creating a personalized risk profile and screening program.

EH: What else may be keeping us from making better progress?

OIO:If we could evaluate everyones genetic profile, we could catch the disease as early as possible instead of waiting for people to become ill. Any cancer is potentially curable if discovered early enough.

But right now, too many people dont know that genetic tests are available, too few doctors ask for them, and insurance often denies coverage. Without solving those problems, we cant take full advantage of the power of precision medicine.

EH: What do you mean by precision medicine?

OIO:Im referring to the ability to select the right drug for the right condition at the right time. Using the appropriate treatment when its most effective can help prevent and treat cancers with fewer side effects.

Genetic information enables us to determine who needs chemotherapy, which type is most effective, and when immunotherapy, for example, is more effective. Not all very early cancers are deadly. Some can be closely watched. Some need additional intervention or require a different kind of prevention.

In the next decade, I predict well see this kind of optimized treatment become available for everyone, whether in Nigeria or on the South Side of Chicago. We will make it all happen.

EH: What drew you to the field of medicine?

OIO: My father was a pastor, so when people were sick, they would come to our house for prayers. Some, of course, remained ill, and my father whose unofficial motto was health is wealth would always remark about how wonderful it would be to have a doctor in the family; someone who could provide more help to these people. He strongly encouraged me to learn about medicine.

Olufunmilayo I. Olopade, MD

Although Im the only one of six siblings who became a doctor, I have a sister whos a nurse and a daughter, one of my three children, runs a healthcare company, Cancer IQ, that has created an application to help medical providers track critical genetic information.

EH: What are your current projects and goals?

OIO: Were trying to develop better ways to assess breast cancer risk, particularly through the use of image-based biomarkers in breast MRIs.

We did a study, published in the March 2019 issue of Clinical Cancer Research, showing that scheduling two MRIs a year is preferable to a single yearly mammogram for younger women at high risk for some forms of breast cancer. But MRIs are more expensive than mammograms. And, as I said before, insurance doesnt always cover them.

When I refer to biomarkers, Im suggesting that we have the ability to do extremely accurate assessments using artificial intelligence, which can read millions of MRI images and pick out subtle changes that mammograms cant. So, from the very first screening, we can monitor these women and plan for any potential interventions, if and when they become necessary.

We also want to better understand why certain populations have much lower levels of breast cancer. Individuals of Asian or Hispanic descent, who are less prone to develop certain breast cancers, may help us pinpoint and isolate whatever particular protective factor is involved. That could potentially lead to future preventions and treatments.

And, of course, I also plan to maintain our focus on equity in access, as we continue to study the effects of new drugs on women of African descent and on the entire population. We need to ensure that we fully understand the side effects on the entire range of people taking these drugs.

Premature breast cancer death is unacceptable; too many women die too young. So, our current goal is the same as always: identify the patient, predict the risk, and prevent the cancer.

EH: Whats the most challenging part of your work?

OIO: The toughest thing you face as a doctor is losing a patient. I try to remember that there is great value in creating an end-of-life plan that diminishes pain and suffering and preserves true dignity. As doctors, we have moments of victory and moments when we are humbled by what we do, but to be present with a patient at the end is so important.

Originally posted here:
Olufunmilayo I. Olopade, MD: Cutting Into Breast Cancer Disparities With Genetic Testing - Everyday Health

Posted in Genetics | Comments Off on Olufunmilayo I. Olopade, MD: Cutting Into Breast Cancer Disparities With Genetic Testing – Everyday Health

Tackling Cybersecurity Threats in the Biotechnology Industry – Technology Networks

Posted: August 30, 2022 at 3:00 am

With significant investments being made into biotechnology and research and development (R&D), life science organizations are becoming increasingly profitable targets for cybercriminals. Tremendous strides are being made in terms of scientific discoveries and companies must also keep pace by managing security risks and protecting scientific data.

One cybersecurity report found that ransomware attacks a form of malware that locks users out of their devices or files until a ransom is paid increased by 485% in 2020 compared to 2019, likely influenced by the COVID-19 pandemic. Additionally, another report found that the average total cost of a data breach in the pharmaceutical industry was $5.06 million.

In light of these rising cybersecurity risks and the threats they pose, Technology Networks spoke to Zach Powers, chief information security officer at Benchling, an R&D cloud platform for the biotechnology industry. We discuss why the biotechnology industry is being targeted by cybercriminals, the importance of data security and how the industry can mitigate these threats.

Sarah Whelan (SW): Can you explain what the Benchling R&D Cloud is, and how it is designed to advance scientific research and development? How can this benefit small academic laboratories through to large-scale biotechnology companies?

Zach Powers (ZP): Benchling was started with a vision of making research and development what its meant to be a collaborative process to turn ideas into scientific progress. In the past few years with the pandemic, this vision has felt more urgent and important than ever. Now, more than 200,000 scientists use Benchlings R&D Cloud as a central source of truth for biotech R&D to centralize data, improve collaboration and access insights, ultimately accelerating the path to discovery.

Looking to examples of how our R&D Cloud facilitates progress in the scientific community we helped Syngenta go from data silos to data as an advantage, now with a data infrastructure that serves 90 locations across different languages, regulations and time zones in their mission to build crops that require fewer inputs while producing great outputs. Using Benchling, Syngenta reported a 72% improvement in sharing data across geos and a large team.

SW: What considerations need to be made in terms of data security for these types of cloud-based platforms?

ZP: Biotech organizations generate revenue based on intellectual property, and if compromised, a great deal of revenue stands to be lost. These organizations are also highly regulated due to the potential human impact of their products and complying with regulations can make or break the organizations ability to compete.

Both of these factors mean that for a cloud-based platform like Benchling, maintaining industry-leading security, privacy and compliance standards for biotech customers is paramount. Enterprise software as a service (SaaS) companies have a responsibility to develop cloud software and infrastructure securely. To do this, they use automated vulnerability management, routine penetration testing, asset management, configuration management, threat detection and response engineering, etc. The end result is that many cloud software products undergo more security scrutiny, on a more frequent basis, than on-premises technologies do. Not all cloud products are the same when it comes to security, but it is becoming increasingly common for enterprise SaaS companies to approach security in this way. When evaluating cloud platforms, customers should evaluate how much an enterprise SaaS company invests in security on an ongoing basis; is there an economy of scale on security that the customer can benefit from?

SW: How important is data security and governance to the industry, and how has this changed over the years as new discoveries are made and biotechnology becomes a more lucrative target for cybercriminals?

ZP: In recent years, threat actors have become more advanced and are highly funded, educated and organized businesses. Whats more, the most dangerous threat actors are being employed by adversaries of the USA and European Union. These organizations are in business to make profits, and many even have revenue targets. They aim to gain illegal access to some of the worlds most sensitive intellectual property for financial gain.

Pharmaceutical companies are now routinely targeted and attacked by these advanced threat actors, and in 2021 almost all (98%) of pharmaceutical companies experienced at least one security intrusion. In fact, over 20% of businesses have lost business-critical data or intellectual property in the last year alone.

It is clear that robust data security and governance are more important than ever, especially as the biotechnology industry continues to increase in value with the influx of valuable data it generates.

SW: What lessons do you think life sciences and biotechnology institutions can take from other industries regarding managing security risks?

ZP: Managing security risks appropriately today requires engineering, automation, real-time analytics, threat intelligence, significant tooling etc. It also takes a strategy of applying security throughout an organization, with multiple layers of defense, points of detection and built-in response options. This level of investment can seem daunting, but against adversaries who are well funded and are singularly focused on their targets, doing less only makes it easier for a threat actor to accomplish their goals. In the security industry, we often talk about the cost to the attacker and how appropriately investing in security can raise the cost sufficiently to either deter an attacker or slow down their attacks sufficiently for detection mechanisms to trigger and response plans to be executed. Threat actors consider the cost to carry out an attack; it is a business after all. Biotech institutions have the ability to influence that cost model.

When evaluating whether to invest in security at this level, many life sciences and biotech institutions have sticker shock as the cost of security is rising rapidly year over year. The advice I give biotech institutions is to look at how many other industries have taken advantage of the economies of scale that mature cloud computing companies can offer on security, resiliency, disaster response and more. If a biotech institution is not ready to invest materially in security themselves, building out the type of world-class security program and capabilities necessary to protect data today, then they can still get secure outcomes by moving their data and workflows into cloud platforms that have invested materially in security. More times than not, mature cloud platforms have invested orders of magnitude more in security than their customers do and continue to on an ongoing basis. No security strategy is perfect, but a strategy that takes advantage of the economies of scale on security that mature cloud platforms provide tends to fare far better than not.

There is another fundamental benefit to approaching security in this way. The adoption of a cloud-first strategy can significantly increase a biotech institutions data liquidity. Cloud architectures excel at enabling data to be found, to be accessed by those who need it, be interoperable between disparate systems and to be reusable. These are known as the FAIR data principles. It is a key focus for biotech institutions today, which have struggled with data residing in disparate, on-premises silos for years.

We can again draw lessons from many other industries, looking at how they evolved and profited from greater data liquidity. For example, enterprise SaaS, banking and healthcare each came to view cloud computing and more modern security as keys to unlocking data liquidity, supporting rapid growth and unparalleled innovation. If data liquidity is the destination, then the easiest road to take is via cloud computing and data platforms. Cloud computing and data platforms bring consistency in data modeling, easily allow for programmatic interfaces, allow for easier governance and security assurance and allow people to find, access and use data readily.

SW: What changes do you think are needed in the future to ensure data security as science advances? What are the biggest challenges that need to be addressed?

ZP: One of the biggest challenges I see is a distrust in cloud technology, which is, unfortunately, a more common sentiment in biotech, particularly in Europe. A lot of biotech institutions are still adhering to a security strategy from the late 1990s, using on-premises technology and essentially using firewalls as the first and only line of defense. More times than not, maintaining an on-premises strategy exposes you to more risk because 100% of the security responsibility and resourcing is on you. Most companies that distrust cloud computing are actually less secure than the cloud providers they distrust.

There are many myths about whether or not cloud computing is secure and its important to separate fact from fiction. When we look at breach statistics, nothing in the data says that on-premises technologies are more secure. But beyond taking a data-driven approach to making security decisions, the most important lens I can offer to change attitudes around the security of cloud computing is that of economies of scale. Companies that adopt cloud and enterprise SaaS take advantage of economies of scale on security that modern software companies provide. Enterprise SaaS companies have a responsibility for security, and they have security capabilities and teams beyond what most companies can afford.

Its the same with Benchling, security is an integral part of the product were offering to our customers. To this aim, we invest far more in security than most customers can afford to, and we have an abundance of expertise. Benchling embeds security engineering into our software development lifecycle and cloud infrastructure operations. Vulnerability testing happens daily, all code checked into production undergoes security testing and any security issues found are fixed within industry-leading service level agreements.

Biotech institutions can get a more secure outcome by taking advantage of cloud software and platforms. We take care of the hard stuff in security so that our customers can focus on advancing science and delivering humanity-impacting products.

Zach Powers was speaking to Sarah Whelan, Science Writer for Technology Networks.

Link:
Tackling Cybersecurity Threats in the Biotechnology Industry - Technology Networks

Posted in Biotechnology | Comments Off on Tackling Cybersecurity Threats in the Biotechnology Industry – Technology Networks

Pak-Turk-Kazakh Youth Forum on Biotech to be held in Sept – The Nation

Posted: August 30, 2022 at 3:00 am

ISLAMABAD Three-day Pakistan-Turkey-Kazakhstan Youth Forum on Biotechnology will be arranged in the month of September with an emphasis on increasing the share of Muslim countries in the biotechnology global market.

The forum, to be held from September 13-15, is being sponsored by COMSTECH-the OIC Standing Committee for Scientific and Technological Cooperation, Islamic Organization for Food Security (IOFS) and Islamic Cooperation Youth Forum (ICYF), an official of COMSTECH told APP.

The academics, students and researchers from the OIC countries are likely to participate in the forum.

The global biotechnology market is anticipated to reach a market value of US$ 775 billion by 2024 with an annual growth rate of 7.7%.

Increased spending on biotechnology research and development, favourable initiatives by governments, global food security and the increasing need for emerging technologies are some of the factors influencing this growth.

Unfortunately, the share of Muslim countries in this global market of biotechnology is very small and needs to be increased.

This proposed tripartite youth forum (Pakistan-Turkey-Kazakhstan) will help promote excellence and competence in the field of agricultural biotechnology among Muslim countries. The theme of the forum Agriculture Biotechnology aims at providing the best knowledge and resources to young participants to advance their research goals, the official informed.

The youth forum will stimulate the desire to collaborate and change the world of agricultural biotechnology and innovation by promoting state-of-the-art practices in biotechnology research and promoting evidence-based practices. The event will include informative talks from young as well as experienced scientists from the three countries.

The event will also include keynote lectures, plenary sessions, oral and poster presentations, discussions and other educational and social events that stimulate several networking opportunities among the young participants of Pakistan, Turkey and Kazakhstan.

The official highlighted that the forum aims to facilitate interactions within the young research community to discuss the latest developments in this rapidly advancing field and find ways to respond to the increasing demands of professionals and communities across the world.

This youth forum is planned to be a hybrid event depending on the preference of the participants in their submitted registration forms.

The topics to be covered during the forum include Genome editing and new breeding technologies, large-scale genomics and genomic selection in crop and livestock breeding, speed breeding for rapid genetic gain, variants of Cas proteins and their potential applications and high throughput phenomics.

See more here:
Pak-Turk-Kazakh Youth Forum on Biotech to be held in Sept - The Nation

Posted in Biotechnology | Comments Off on Pak-Turk-Kazakh Youth Forum on Biotech to be held in Sept – The Nation

How Diabetes and High Blood Pressure Are Linked – TIME

Posted: August 30, 2022 at 2:58 am

High blood pressurealso known as hypertensionand Type 2 diabetes are two of the most common medical conditions in the U.S. Unfortunately, they often occur together. Some research has found that 85% of middle-aged or older adults who have Type 2 diabetes also have hypertension, and both conditions elevate a persons risk for heart disease, stroke, and kidney disease.

These increased risks are significant, and in some cases grave. Researchers have found that people with Type 2 diabetes are up to four times more likely to develop cardiovascular disease than those who dont have the condition. People with diabetes are also twice as likely to die of cardiovascular problems. The leaps in rates of stroke, kidney failure, and other deadly complications are also substantial for people who have both high blood pressure and diabetes.

Why do these conditions so often show up in tandem? Experts are still trying to nail down the precise connections, but they say excess weight may play a part. Many people who have hypertension and Type 2 diabetes also have obesity, and this triumvirate, as some researchers have termed it, is associated with metabolic and endocrine problems that overlap and promote disease. Obesity seems to be fertile soil for both, says Dr. Srinivasan Beddhu, a professor of internal medicine at the University of Utah School of Medicine.

Also, the sheer commonness of hypertension all but ensures that most people with Type 2 diabetes will end up with both diseases. Roughly half of all U.S. adults have hypertension, and that percentage goes up with age. It can develop as early as [ages] 30 to 42, but in most cases, by the time youre in your 50s, its there, says Dr. George Bakris, a professor of medicine at the University of Chicago. Although hypertension often precedes Type 2 diabetes, Bakris says, diabetes is increasingly common in young adults and even children. Its more important than ever to keep an eye out for both conditions, perhaps especially if youre overweight or obese.

Here, experts explain how high blood pressure and Type 2 diabetes cause trouble in combination, as well as how to manage the conditions and reduce their associated risks.

Read More: These New Developments Could Make Living With Type 2 Diabetes More Manageable

Every time a heart beats, it sends blood out into the body via the circulatory system. In between beats, the heart fills with blood. A persons blood pressure refers to two different but related measurements of this cycle. The first, known as systolic blood pressure, is the pressure inside the arteries when the heart beats and pumps out blood. The second measurement, known as diastolic blood pressure, is the pressure inside the arteries when the heart is resting and filling with blood. These two numbers are usually presented together, and they almost always rise and fall in unison. In the U.S., blood-pressure scores higher than 130/80 mm Hg are considered hypertensive.

Bakris says hypertension is often called a silent killer because it may cause no symptoms. Even when a persons blood pressure is dangerously high, the symptoms that develop are so common and nonspecificmeaning they turn up for all sorts of reasonsthat you may not connect them with high blood pressure. Dizziness, headaches, and blurry vision are among these nonspecific symptoms. By the time they set in, a persons blood pressure may have been elevatedand doing damagefor several years. What sort of damage? High blood pressure can stretch or injure your arteries in ways that raise your risk for heart disease, arterial disease, stroke, and other cardiovascular complications. High blood pressure also increases stress on the kidneys and some other organs.

Type 2 diabetes is a medical condition defined by high blood-sugar levels. These high levels are caused by problems related to insulin, which is a hormone that signals to the bodys cells that they need to absorb blood sugar. In people with Type 2 diabetes, the cells become resistant to insulin, meaning they do not properly absorb blood sugar. As with hypertension, the early symptoms of Type 2 diabetesfrequent urination, blurry vision, dramatic hunger spikesmay not raise immediate red flags. If someone isnt staying on top of their doctors appointments, they may not be aware that one or both of these conditions is present.

How do these conditions combine in ways that contribute to health problems? Both affect the small blood vessels, says Dr. Mattias Brunstrom, a hypertension specialist and physician researcher at Umea University in Sweden. Diabetes affects the vessels in ways that make them stiffer, and high blood pressure impairs their function. This stacking of arterial damage helps explain why the combination of the two conditions is associated with cardiovascular problems, including higher rates of heart disease and stroke.

At the same time, both hypertension and Type 2 diabetes may also promote higher-than-normal levels of blood sugar. Elevated blood sugar can damage the cells of the kidneys (as well as the heart and blood vessels). Kidney diseaseand ultimately kidney failureis a common complication among people with both of these conditions. If you have [systolic] blood pressure consistently above 180, within 12 to 15 years, you will be on dialysis, Bakris says, referring to a medical procedure that removes, filters, and returns the blood to someone whose kidneys are no longer up to it. Elevated blood sugar caused by Type 2 diabetes further damages kidney cells, and increases the odds that the kidneys will struggle or fail to perform their job.

Although cardiovascular and renal problems are two of the most common complications, hypertension and Type 2 diabetes can cause or contribute to a wide range of health problemsfrom dementia to blindness. Both affect the vasculature, which can impair the health of any organ system, Brunstrom says.

Fortunately, there are effective ways to manage both conditions and therefore reduce all of these health risks.

Read More: The Truth About Fasting and Type 2 Diabetes

As is the case with most common health conditions, experts say that a combination of lifestyle changes and prescription drugs are often an effective one-two punch for people with both hypertension and Type 2 diabetes.

First, I would say that lifestyle changes are the basics of all disease management, Brunstrom says. He re-emphasizes the strong associations linking hypertension and Type 2 diabetes to obesity, and the role excess weight plays in exacerbating many health complications. Obesity or overweight is a huge driver of both these conditions, so weight management would be very crucial, he says. Diet, exerciseany way you can get your weight down is good.

Even if youre not losing weight, exercise is still beneficial. It increases circulation around the body and improves function of the small vessels, which might get [blood] pressure down, he says. It might also improve the sensitivity to insulin and reduce glucose. Thats all good stuff. Even short of sweaty exercise sessions, spending less time sitting or in a sedentary positionwalking, for example, or doing chores around the house on your feetmay be helpful.

When it comes to eating, Brunstrom highlights the DASH diet, which is endorsed by the National Heart, Lung, and Blood Institute for the management of hypertension. (DASH stands for dietary approaches to stop hypertension.) The DASH diet involves limiting your intake of saturated fats, which are common in red meat and fatty dairy products, and also cutting down on your intake of salt and sugary foods and drinks. Meanwhile, the DASH diet recommends eating lots of fruits and vegetables. Other experts endorse these eating habits. I always tell my patients to eat healthy, which means more fruits and vegetables, less red meat, fewer high-carbohydrate foods, says the University of Utahs Beddhu.

Recently, some researchers have examined the benefits of intermittent fasting plans for the management of Type 2 diabetes. These approaches involve limiting or eliminating all caloric intake for an extended period of timeusually 16 hours or longer. Theres evidence that they may be beneficial. They also appear to be safe for people with early or mild disease. But if you have diabetes and are on medications, these diets can wreak havoc, Bakris says. If you want to try that, you need the help of a physician or accredited diabetes dietitian.

Weight-loss surgery may be a treatment option worth considering. Recent research shows that bariatric surgery has helped both young people and adults get better control of their diabetes and hypertension. In some cases, especially those involving teenagers, weight-loss surgery has removed the need for medications or even eliminated the diseases entirely.

Apart from surgery and lifestyle interventions, experts agree that prescription medications are almost always necessary to manage these diseases. You can reduce your pill burden if youre really good on the lifestyle sideso eating right, reducing sodium intake, exercising regularly, Bakris says. But even on the low end, most people with diabetes and hypertension are going to require four to six medications.

Others agree that pills are pretty much unavoidable. I always compare [taking] them to doing your taxes or brushing your teeth, says Dr. Tom Brouwer, a cardiology resident and researcher at Amsterdam University Medical Centres in the Netherlands. Its not fun, but you need to do it.

In the U.S., medical guidelines recommend that doctors aim to get people with both hypertension and diabetes down to blood-pressure scores below 130/80 mm Hg. Theres some ongoing debate about whether targeting even lower numbers would be beneficial. Brouwer has conducted research in this area, and he says that in many cases hes a proponent of aiming for a systolic BP of 120. If a patient tolerates it, I tend to try to lower their blood pressure all the way to 120, he says.

There are many different drugs used to treat people with both hypertension and Type 2 diabetes. But two of the most popular options are angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers, both of which help relax the arteries and so assist blood flow. Apart from being effective for hypertension, these drugs also help protect the kidneys. Diuretics (drugs that increase urination), as well as beta blockers and calcium channel blockers, are all common treatments.

Read More: People With Diabetes Are More Vulnerable to Heart Disease. How to Reduce the Risk

With these three drugs, an overwhelming majority of patients get to the target blood pressure, Brouwer says.

For those at risk for hypertension, diabetes, or both, experts say that all the lifestyle measures abovea good diet, exercise, and maintaining a healthy weightare among the best ways to lower your risks. By following your doctors drug recommendations and trying to live a healthier life, you can protect yourself from serious complications. I tell patients: you can help yourself, Bakris says. But you have to put in the effort.

More Must-Read Stories From TIME

Contact us at letters@time.com.

Here is the original post:
How Diabetes and High Blood Pressure Are Linked - TIME

Posted in Diabetes | Comments Off on How Diabetes and High Blood Pressure Are Linked – TIME

The #1 Root Cause of Diabetes, Say Physicians Eat This Not That – Eat This, Not That

Posted: August 30, 2022 at 2:58 am

Diabetesis a common condition that affects one in 10 people, that's over 37 million Americans, according to the Centers for Disease Control and Prevention While that's an alarming number, there are ways to help lower the risk. Dr. Tomi Mitchell, a Board-Certified Family Physician with Holistic Wellness Strategies tells us, "Diabetes is a serious medical condition that can lead to several health complications, including heart disease, kidney damage, and blindness. Fortunately, there are several things that people can do to reduce their chance of developing diabetes. Here are five lifestyle changes that can help to prevent diabetes. Read onand to ensure your health and the health of others, don't miss these Sure Signs You've Already Had COVID.

Dr. Mitchell says, "Diabetes is a chronic disease that occurs when the pancreas does not produce enough insulin or when the body cannot effectively use the insulin it produces. Insulin is a hormone that regulates blood sugar. When blood sugar levels are too high, it can strain the organs and lead to complications such as heart disease, stroke, kidney disease, and vision problems. There are two main types of diabetes: type 1 and type 2. Type 1 diabetes usually develops in childhood or adolescence and is caused by an autoimmune reaction that destroys the beta cells in the pancreas that produce insulin. Type 2 diabetes usually develops in adulthood and is characterized by insulin resistance, when the body cannot effectively use the insulin it produces. Diabetes can be managed through lifestyle changes such as diet, exercise, and medication.

According to the Centers for Disease Control and Prevention (CDC), more than 30 million people in the United States have diabetes. However, it is estimated that one in four is undiagnosed and unaware of the condition. This is particularly concerning because diabetes can lead to several serious health complications, including heart disease, stroke, kidney disease, and blindness. That is why it is so important to get screened for diabetes if you think you may be at risk. If you have a family history of diabetes, your doctor might recommend getting screened at an earlier age. There are several ways to test for diabetes, but the most common is the A1C test. This test measures your average blood sugar levels over two to three months and can be done at your doctor's office or a local clinic. If you have diabetes, it is essential to work with your healthcare team to manage your condition and prevent complications. People with diabetes can live long and healthy lives with proper treatment and care."

Dr. Mitchell explains, "Being overweight or obese is the number one risk factor for type 2 diabetes. About 80 percent of people with this form of diabetes are overweight or obese. There are several reasons why carrying extra weight increases your risk of developing diabetes. First, excess body fat makes it difficult for the body to use insulin effectively. When the body can't use insulin properly, blood sugar levels rise. This is known as insulin resistance. Insulin resistance is a major cause of type 2 diabetes. In addition, carrying extra weight puts extra strain on the body's organs and systems, including the pancreas, which produces insulin. Over time, this can lead to damage and dysfunction. Finally, fat tissue produces hormones contributing to insulin resistance and high blood sugar levels. For all these reasons, people who carry extra weight are at a much higher risk of developing diabetes than those of a healthy weight."

According to the Centers for Disease Control and Prevention, "Not getting enough physical activity can raise a person's risk of developing type 2 diabetes. Physical activity helps control blood sugar (glucose), weight, and blood pressure and helps raise "good" cholesterol and lower "bad" cholesterol. Adequate physical activity can also help reduce the risk of heart disease and nerve damage, which are often problems for people with diabetes."

Dr. Mitchell reminds us, "Eating a healthy diet is essential for many reasons. It can help you maintain a healthy weight, have more energy, and avoid heart disease, stroke, and diabetes. Diabetes is a condition that affects how your body uses blood sugar. If you have diabetes, your body either doesn't make enough insulin or can't use it as well as it should. This causes blood sugar levels to rise. Over time, high blood sugar levels can lead to serious health problems, such as heart disease, kidney disease, nerve damage, and eye problems. Eating a healthy diet is one of the best ways to prevent or delay type 2 diabetes. A healthy diet includes fruits, vegetables, whole grains, and lean proteins. Limiting sugar, saturated fat, and trans fat is also essential. If you already have diabetes, eating a healthy diet can help you control your blood sugar levels. It can also help you prevent or delay complications of the disease."6254a4d1642c605c54bf1cab17d50f1e

Dr. Mitchell says, "Smoking is a leading cause of preventable death in the United States and a significant risk factor for developing diabetes. Smokers are more likely to develop type 2 diabetes than non-smokers, and the risk increases with the number of cigarettes smoked daily. Quitting smoking not only lowers your risk of developing diabetes but also helps to improve blood sugar control if you already have the disease. In addition, quitting smoking decreases your chances of developing other serious health problems, such as heart disease, stroke, and cancer. If you smoke, quitting is one of the best things you can do for your health. Talk to your doctor about ways to help you quit smoking for good."

Dr. Mitchell shares, "Monitoring blood sugar is essential in preventing diabetes because it allows people to see how their diet and lifestyle choices affect their blood sugar levels. For example, if someone eats many sugary foods, they might see a spike in their blood sugar levels. By monitoring their blood sugar, they can change their diet or lifestyle to help prevent their blood sugar from reaching diabetic levels. In addition, monitoring blood sugar can also help people with diabetes to keep their condition under control. They can adjust their insulin doses accordingly by knowing their blood sugar levels. Thus, monitoring blood sugar is an essential tool in both preventing and managing diabetes."

Heather Newgen

Read the original:
The #1 Root Cause of Diabetes, Say Physicians Eat This Not That - Eat This, Not That

Posted in Diabetes | Comments Off on The #1 Root Cause of Diabetes, Say Physicians Eat This Not That – Eat This, Not That

Page 247«..1020..246247248249..260270..»